Asperger's disorder and co-morbid bipolar disorder: Diagnostic and treatment challenges

Journal of Child and Adolescent Psychopharmacology

Volumn 17, Issue 2, 2007, Pages 247-255

  Gutkovich, Zinoviy A ^a   Carlson, Gabrielle A ^b   Carlson, Harold E ^c   Coffey, Barbara ^d   Wieland, Natalie ^d  

^a ZUCKER HILLSIDE HOSPITAL   (United States)

^b STONY BROOK UNIVERSITY   (United States)

^c STONY BROOK UNIVERSITY   (United States)

^d NEW YORK UNIVERSITY CHILD STUDY CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; GUANFACINE; HIGH DENSITY LIPOPROTEIN; INSULIN; LITHIUM; METFORMIN; PROLACTIN; RISPERIDONE; TOPIRAMATE; TRIACYLGLYCEROL; ZIPRASIDONE;

ADOLESCENT; ASPERGER SYNDROME; BIPOLAR DISORDER; CASE REPORT; COMORBIDITY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIAGNOSTIC VALUE; HUMAN; MALE; REVIEW;

ADOLESCENT; ASPERGER SYNDROME; BIPOLAR DISORDER; HUMANS; MALE; PSYCHOTROPIC DRUGS;

EID: 34249663714     PISSN: 10445463     EISSN: None     Source Type: Journal    
DOI: 10.1089/cap.2007.1723     Document Type: Review

References (27)

1. th ed., Text Revision (DSM-IV-TR). Washington, D.C., American Psychiatric Association, 2000.
2. Baptista T. Martinez J. Lacruz A. Rangel N. Beaulieu S. Serrano A. Arape Y. Martinez M. de Mendoza S. Teneud L. Hernandez L: Metformin for prevention of weight gain and insulin resistance with olanzapine: A double-blind placebo-controlled trial. Can J Psychiatry - Revue Canadienne de Psychiatrie 51:192-196, 2006.
3. Bolton PF, Pickles A, Murphy M, Rutter M: Autism, affective and other psychiatric disorders: Patterns of familial aggregation. Psychol Med 28:385-395, 1998.
4. Campbell M, Fish B, Korein J, Shapiro T, Collins P, Koh C: Lithium and chlorpromazine: A controlled cross-over study of hyperactive severely disturbed young children. J Autism Child Schizophr 2:234-263, 1972.
5. Carlson GA, Meyer SE: Phenomenology and diagnosis of bipolar disorder in children, adolescents, and adults: Complexities and developmental issues. Dev Psychopathol 18:939-69, 2006.
6. Correll CU, Penzner JB, Parikh UH, Mughal T, Javed T, Carbon M, Malhotra AK: Recognizing and monitoring adverse events of second-generation antipsychotics in children and adolescents. Child Adolesc Psychiatric Clin N Am 15:177-206, 2006.
7. Dejong S, Frazier JA: Bipolar disorder in children with pervasive developmental disorder. In: Bipolar Disorder in Childhood and Early Adolescence. Edited by Geller B, DelBello M.P. New York, Guildford Press, 2002, pp 51-75.
8. DeLong GR. Dwyer JT: Correlation of family history with specific autistic subgroups: Asperger's syndrome and bipolar affective disease. J Autism Devel Disord 18:593-600, 1988.
9. Frazier JA, Doyle R, Chiu S, Coyle JT: Treating a child with Asperger's disorder and comorbid bipolar disorder. Am J Psychiatry 159:13-21, 2002.
10. Geller B, Zimerman B, Williams M, Bolhofner K, Craney JL, Delbello MP, Soutullo CA: Diagnostic characteristics of 93 cases of a prepubertal and early adolescent bipolar disorder phenotype by gender, puberty, and comorbid attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol 10:157-164, 2000.
11. Hollander E, Wasserman S, Swanson EN, Chaplin W, Schapiro ML, Zagursky K, Novotny S: A double-blind placebo-controlled pilot study of olanzapine in childhood/adolescent pervasive developmental disorder.J Child Adolesc Psychopharmacol 16:541-548, 2006.
12. Kane JM, Barrett EJ, Casey DE, Correll CU, Gelenberg AJ, Klein S, Newcomer JW: Metabolic effects of treatment with atypical antipsychotics. J Clin Psychiatry 65:1447-1455, 2004.
13. Kerbeshian J, Burd L: Case study: Comorbidity among Tourette's syndrome, autistic disorder, and bipolar disorder. J Am Acad Child Adolesc Psychiatry 35:681-685, 1996.
14. Kerbeshian J, Burd L, Fisher W: Lithium carbonate in the treatment of two patients with infantile autism and atypical bipolar symptomatology. J Clin Psychopharmacol: 7:401-405, 1987.
15. Klein DJ, Cottingham EM, Sorter M, Barton BA, Morrison JA: A randomized, double-blind, placebo-controlled trial of metformin treatment of weight gain associated with initiation of atypical antipsychotic therapy in children and adolescents. Am J Psychiatry 163:2072-2079, 2006.
16. Koukopoulos A, Sani G, Koukopoulos AE, Albert MJ, Girardi P, Tatarelli R: Endogenous and exogenous cyclicity and temperament in bipolar disorder: Review, new data and hypotheses. J Affect Disord 96:165-175, 2006.
17. Kyte ZA, Carlson GA, Goodyer IM: Clinical and neuropsychological characteristics of child and adolescent bipolar disorder. Psychol Med 36:1197-1211, 2006.
18. Lee JM, Okumura MJ, Davis MM, Herman WH, Gurney JG: Prevalence and determinants of insulin resistance among U.S. adolescents: A population-based study. Diabetes Care 29:2427-2432, 2006.
19. McCracken JT, McGough J, Shah B, Cronin P, Hong D, Aman MG, Arnold LE, Lindsay R, Nash P, Hollway J, McDougle CJ, Posey D, Swiezy N, Kohn A, Scahill L, Martin A, Koenig K, Volkmar F, Carroll D, Lancor A, Tierney E, Ghuman J, Gonzalez NM, Grados M, Vitiello B, Ritz L, Davies M, Robinson J, McMahon D: Research Units on Pediatric Psychopharmacology Autism Network. Risperidone in children with autism and serious behavioral problems. N Engl J Med 347:314-321, 2002.
20. Pavuluri MN, Schenkel LS, Aryal S, Harral EM, Hill SK, Herbener ES, Sweeney JA. Neurocognitive function in unmedicated manic and medicated euthymic pediatric bipolar patients. Am J Psychiatry 163:286-293, 2006.
21. Posey DJ, Erickson CA, Stigler KA, McDougle CJ: The use of selective serotonin reuptake inhibitors in autism and related disorders. J Child Adolesc Psychopharmacol 16:181-186, 2006.
22. Research Units on Pediatric Psychopharmacology Autism Network. Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity. Arch Gen Psychiatry 62: 1266-1274, 2005.
23. Sovner R: Limiting factors in the use of DSM-III criteria with mentally ill/mentally retarded persons. Psychopharmacol Bull 22:1055-1059, 1986.
24. Stahlberg O, Soderstrom H, Rastam M, Gillberg C.: Bipolar disorder, schizophrenia, and other psychotic disorders in adults with childhood onset AD/HD and/or autism spectrum disorders. J Neural Transm 111: 891-902, 2004.
25. Steingard R, Biederman J: Lithium responsive manic-like symptoms in two individuals with autism and mental retardation. J Am Acad Child Adolesc Psychiatry 26:932-935, 1987.
26. Towbin KE, Pradella A, Gorrindo T, Pine D, Leibenluft, E: Autism spectrum traits in children with mood and anxiety disorders. J Child Adolesc Psychopharmacol 15:452-464, 2005.
27. Wozniak J, Biederman J, Faraone SV, Frazier J, Kim J, Millstein R, Gershon J, Thornell A, Cha K, Snyder JB. Mania in children with pervasive developmental disorder revisited. J Am Acad Child Adolesc Psychiatry 36: 1552-1559, 1997.